Patent Assignment
Reel/Frame 073067/0650
Change of Name
Recorded: 2025-08-28
Pages: 2
Assignor
PSIVIDA US, INC.
Executed: 2018-03-28
Assignee
EYEPOINT PHARMACEUTICALS US, INC.
480 PLEASANT STREET, SUITE C400, WATERTOWN, MASSACHUSETTS, 02472
Covered Property
(1)
Bioerodible Ocular Drug Delivery Insert and Therapeutic Method
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 21, 2022
From: SAIM, SAID; HOWARD-SPARKS, MICHELLE; PAGGIARINO, DARIO; KARZOUN, BASEL
To: EYEPOINT PHARMACEUTICALS, INC.
Reel/Frame 061165/0912 →
Assignment of Assignor's Interest
Aug 28, 2025
From: CHEN, JIANBING
To: CONTROL DELIVERY SYSTEMS, INC.
Reel/Frame 072675/0223 →
Merger and Change of Name
Aug 28, 2025
From: PSIVIDA INC.; CONTROL DELIVERY SYSTEMS, INC.
To: PSIVIDA INC.
Reel/Frame 072675/0235 →
Change of Name
Aug 28, 2025
From: PSIVIDA INC.
To: PSIVIDA US, INC.
Reel/Frame 072675/0250 →
Assignment of Assignor's Interest
Aug 28, 2025
From: EYEPOINT PHARMACEUTICALS US, INC.
To: EYEPOINT PHARMACEUTICAL, INC.
Reel/Frame 072675/0256 →
Change of Name
Jul 1, 2026
From: EYEPOINT PHARMACEUTICALS, INC.
To: EYEPOINT, INC.
Reel/Frame 075945/0459 →